Home RxNorm 1244634 betamethasone valerate 1.2 MG/ML Topical Foam Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1244634
RxNorm name betamethasone valerate 1.2 MG/ML Topical Foam
Display name Betamethasone (Topical)
Full name betamethasone valerate 1.2 MG/ML Topical Foam
Term type SCD
Status Active
Strength 0.12%
Dose form Foam
Route Topical
Updated 2026-09-09 14:39:03 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 032012
Active start 032012
Multiple ingredient NO
Branded NO Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength betamethasone valerate 1.2 MG / 1 ML betamethasone betamethasone valerate
Derived Ingredient Concepts# FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 45802-053-01 45802-053 Betamethasone Valerate Betamethasone Valerate Padagis Israel Pharmaceuticals Ltd ANDA078337 45802-053-02 45802-053 Betamethasone Valerate Betamethasone Valerate Padagis Israel Pharmaceuticals Ltd ANDA078337 46708-708-31 46708-708 Betamethasone valerate Betamethasone valerate Alembic Pharmaceuticals Limited ANDA215832 46708-708-50 46708-708 Betamethasone valerate Betamethasone valerate Alembic Pharmaceuticals Limited ANDA215832 51672-4188-3 51672-4188 Betamethasone Valerate Betamethasone Valerate Sun Pharmaceutical Industries, Inc. ANDA208204 51672-4188-7 51672-4188 Betamethasone Valerate Betamethasone Valerate Sun Pharmaceutical Industries, Inc. ANDA208204 62332-708-31 62332-708 Betamethasone valerate Betamethasone valerate Alembic Pharmaceuticals Inc. ANDA215832 62332-708-50 62332-708 Betamethasone valerate Betamethasone valerate Alembic Pharmaceuticals Inc. ANDA215832 70700-141-19 70700-141 Betamethasone Valerate Betamethasone Valerate Foam Xiromed, LLC. ANDA210639 70700-141-20 70700-141 Betamethasone Valerate Betamethasone Valerate Foam Xiromed, LLC. ANDA210639
Drugs@FDA Applications# Application, NDC, Name table Application NDC Name Marketing category Labeler ANDA078337 45802-053 Betamethasone Valerate Betamethasone Valerate ANDA Padagis Israel Pharmaceuticals Ltd ANDA215832 46708-708 Betamethasone valerate Betamethasone valerate ANDA Alembic Pharmaceuticals Limited ANDA208204 51672-4188 Betamethasone Valerate Betamethasone Valerate ANDA Sun Pharmaceutical Industries, Inc. ANDA210639 70700-141 Betamethasone Valerate Betamethasone Valerate Foam ANDA Xiromed, LLC.
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 26 matching rows.
NDC11, Source, Active table NDC11 Source Active 00378818050 rxnav_ndcs yes 00378818099 rxnav_ndcs yes 45802005301 rxnav_ndcs yes 45802005302 rxnav_ndcs yes 46708070831 rxnav_ndcs yes 46708070850 rxnav_ndcs yes 50742031501 rxnav_ndcs yes 50742031550 rxnav_ndcs yes 51672418803 rxnav_ndcs yes 51672418807 rxnav_ndcs yes 62332070831 rxnav_ndcs yes 62332070850 rxnav_ndcs yes 70700014119 rxnav_ndcs yes 70700014120 rxnav_ndcs yes 17630001000 rxnav_historical_indirect 17630001001 rxnav_historical_indirect 17630001002 rxnav_historical_indirect 51125040705 rxnav_historical 51125040706 rxnav_historical 58118993505 rxnav_historical 63032002100 rxnav_historical_indirect 63032002101 rxnav_historical_indirect 63032002112 rxnav_historical_indirect 63032002150 rxnav_historical_indirect 63094234501 rxnav_historical_indirect 63094234505 rxnav_historical_indirect
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 5 matching rows.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 5 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective dc5dfd3e-7762-40c8-880e-c7db80d87749 betamethasone valerate 0.12 % Topical Foam [PSN] · betamethasone valerate 1.2 MG/ML Topical Foam [SCD] · betamethasone valerate 0.12 % Topical Foam [SY] 3 10 Betamethasone Valerate Foam, 0.12% 20240331 3b6fa573-de04-4626-a39a-dca39def6df2 betamethasone valerate 0.12 % Topical Foam [PSN] · betamethasone valerate 1.2 MG/ML Topical Foam [SCD] · betamethasone valerate 0.12 % Topical Foam [SY] 3 4 Betamethasone Valerate Foam, 0.12% Rx Only For Dermatologic Use Only Not for Ophthalmic Use 20240823 dee8f6d1-b0ba-3c56-f08d-eb6283b0b250 betamethasone valerate 0.12 % Topical Foam [PSN] · betamethasone valerate 1.2 MG/ML Topical Foam [SCD] · betamethasone valerate 0.12 % Topical Foam [SY] 3 4 Betamethasone Valerate Foam, 0.12% 20230508 7c96b978-25ff-44c2-bc9c-30ff5e34cffb betamethasone valerate 0.12 % Topical Foam [PSN] · betamethasone valerate 1.2 MG/ML Topical Foam [SCD] · betamethasone valerate 0.12 % Topical Foam [SY] 3 3 Betamethasone Valerate Foam, 0.12% 20260323 75d70e76-023c-4a00-954d-79a697bed80f betamethasone valerate 0.12 % Topical Foam [PSN] · betamethasone valerate 1.2 MG/ML Topical Foam [SCD] · betamethasone valerate 0.12 % Topical Foam [SY] 3 1 Betamethasone Valerate Foam, 0.12% Rx Only For Dermatologic Use Only Not for Ophthalmic Use 20250925
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective 7c96b978-25ff-44c2-bc9c-30ff5e34cffb Betamethasone Valerate Foam, 0.12% Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. 20260323 75d70e76-023c-4a00-954d-79a697bed80f Betamethasone Valerate Foam, 0.12% Rx Only For Dermatologic Use Only Not for Ophthalmic Use Alembic Pharmaceuticals Limited 20250925 3b6fa573-de04-4626-a39a-dca39def6df2 Betamethasone Valerate Foam, 0.12% Rx Only For Dermatologic Use Only Not for Ophthalmic Use Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited 20240823 dc5dfd3e-7762-40c8-880e-c7db80d87749 Betamethasone Valerate Foam, 0.12% Padagis Israel Pharmaceuticals Ltd 20240331 dee8f6d1-b0ba-3c56-f08d-eb6283b0b250 Betamethasone Valerate Foam, 0.12% Xiromed, LLC. | Chemo Research, S.L. | Laboratorios Liconsa, S.A. 20230508 801bac90-2ed7-4f68-9fa4-be1705b1f98c PRESCRIBING INFORMATION Betamethasone Valerate Foam, 0.12% Rx Only For Dermatologic Use Only Not for Ophthalmic Use Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. 20230203 1faf8d75-af60-4438-b6d5-c1b06d5ac703 Mylan Pharmaceuticals Inc. 20170330 3e251f86-e8d9-4dd5-b889-62563daf9d32 National Council for Prescription Drug Programs 20130213 7a7af908-79eb-41d9-94e8-d6e9114be998 National Council for Prescription Drug Programs 20130213 910cd7fe-abe1-4fca-bf70-0a0c5e6b3fd7 National Council for Prescription Drug Programs 20120724 d2fd0bd1-72db-4cbf-846f-b92115e499d7 National Council for Prescription Drug Programs 20120724
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC C05AA Corticosteroids ATC1-4 betamethasone ATC S03BA Corticosteroids ATC1-4 betamethasone ATC S02BA Corticosteroids ATC1-4 betamethasone ATC R01AD Corticosteroids ATC1-4 betamethasone ATC A07EA Corticosteroids acting locally ATC1-4 betamethasone ATC S01BA Corticosteroids, plain ATC1-4 betamethasone ATC D07AC Corticosteroids, potent (group III) ATC1-4 betamethasone ATC D07XC Corticosteroids, potent, other combinations ATC1-4 betamethasone ATC S01CB Corticosteroids/antiinfectives/mydriatics in combination ATC1-4 betamethasone ATC R03BA Glucocorticoids ATC1-4 betamethasone ATC H02AB Glucocorticoids ATC1-4 betamethasone FDASPL N0000175576 Corticosteroid EPC has_epc betamethasone FDASPL N0000175450 Corticosteroid Hormone Receptor Agonists MOA has_moa betamethasone MEDRT D001623 Betamethasone CHEM has_ingredient betamethasone MEDRT D001624 Betamethasone Valerate CHEM has_ingredient betamethasone valerate MEDRT D003876 Dermatitis, Atopic DISEASE may_treat betamethasone valerate MEDRT D003876 Dermatitis, Atopic DISEASE may_treat betamethasone MEDRT D012628 Dermatitis, Seborrheic DISEASE may_treat betamethasone valerate MEDRT D012628 Dermatitis, Seborrheic DISEASE may_treat betamethasone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with betamethasone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with betamethasone valerate MEDRT D005148 Facial Dermatoses DISEASE may_treat betamethasone MEDRT D005148 Facial Dermatoses DISEASE may_treat betamethasone valerate MEDRT D005533 Foot Dermatoses DISEASE may_treat betamethasone MEDRT D005533 Foot Dermatoses DISEASE may_treat betamethasone valerate MEDRT D006229 Hand Dermatoses DISEASE may_treat betamethasone MEDRT D006229 Hand Dermatoses DISEASE may_treat betamethasone valerate MEDRT D007249 Inflammation DISEASE may_treat betamethasone valerate MEDRT D007249 Inflammation DISEASE may_treat betamethasone MEDRT D007868 Leg Dermatoses DISEASE may_treat betamethasone valerate MEDRT D007868 Leg Dermatoses DISEASE may_treat betamethasone MEDRT D009181 Mycoses DISEASE ci_with betamethasone valerate MEDRT D009181 Mycoses DISEASE ci_with betamethasone MEDRT D011538 Pruritus Ani DISEASE may_treat betamethasone valerate MEDRT D011538 Pruritus Ani DISEASE may_treat betamethasone MEDRT D011565 Psoriasis DISEASE may_treat betamethasone valerate MEDRT D011565 Psoriasis DISEASE may_treat betamethasone MEDRT D016553 Purpura, Thrombocytopenic, Idiopathic DISEASE ci_with betamethasone valerate MEDRT D016553 Purpura, Thrombocytopenic, Idiopathic DISEASE ci_with betamethasone MEDRT D012536 Scalp Dermatoses DISEASE may_treat betamethasone MEDRT D012536 Scalp Dermatoses DISEASE may_treat betamethasone valerate MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa betamethasone valerate MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa betamethasone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa betamethasone valerate MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa betamethasone MEDRT N0000008297 Antipruritic Activity PE has_pe betamethasone valerate MEDRT N0000008297 Antipruritic Activity PE has_pe betamethasone MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe betamethasone valerate MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe betamethasone MEDRT N0000009928 Decreased Cellular Migration PE has_pe betamethasone valerate MEDRT N0000009928 Decreased Cellular Migration PE has_pe betamethasone MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe betamethasone MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe betamethasone valerate MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe betamethasone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe betamethasone valerate MEDRT N0000008700 Decreased Lysosomal Function PE has_pe betamethasone MEDRT N0000008700 Decreased Lysosomal Function PE has_pe betamethasone valerate MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe betamethasone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe betamethasone valerate MEDRT N0000008841 Decreased Protein Synthesis PE has_pe betamethasone MEDRT N0000008841 Decreased Protein Synthesis PE has_pe betamethasone valerate MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe betamethasone MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe betamethasone valerate MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe betamethasone valerate MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe betamethasone
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 1.2 MG/ML ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES ANDA ANDA078337 CODES ANDA ANDA208204 CODES ANDA ANDA210639 CODES ANDA ANDA215832 CODES SNOMEDCT 765088006 CODES VUID 4013754 NAMES Prescribable Synonym betamethasone valerate 0.12 % Topical Foam SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon SOURCES Source National Drug Data File Plus Source Vocabulary SOURCES Source US Edition of SNOMED_CT SOURCES Source Veterans Health Administration National Drug File